YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Life science company MilliporeSigma is expanding in St. Louis with a $76 million investment.
The plans include 170 new jobs as the company expands the capabilities of an existing St. Louis plant to manufacture cancer drugs.
The investment is expected to triple the facility's production capacity for antibody-drug conjugate manufacturing.
Read more from the St. Louis Business Journal.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach